Cambridge-based Broken String Biosciences, a genomics company focused on creating safer cell and gene therapies, announced that it has raised $15M in a Series A round of funding. The investment was co-led by Illumina Ventures and Mérieux Equity Partners, with contributions from HERAN Partners and participation from existing investors Tencent and Dieter von Holtzbrinck Ventures. Broken String Biosciences is dedicated to … Continue reading UK’s Broken String Biosciences raises $15M